Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$3.2B
-
Value change
-
+$130M
-
Put/Call ratio
-
1.5
-
Number of buys
-
140
-
Number of sells
-
-123
-
Price
-
$95.76
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q2 2022
311 filings reported holding CNMD - CONMED Corp - Common Stock as of Q2 2022.
CONMED Corp - Common Stock (CNMD) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
.
Largest 10 shareholders include BlackRock Inc. (4.63M shares), VANGUARD GROUP INC (3.21M shares), EARNEST PARTNERS LLC (1.66M shares), Capital Research Global Investors (1.53M shares), Champlain Investment Partners, LLC (1.34M shares), AMERIPRISE FINANCIAL INC (1.31M shares), STATE STREET CORP (1.05M shares), JPMORGAN CHASE & CO (989K shares), Invesco Ltd. (809K shares), and BANK OF AMERICA CORP /DE/ (777K shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.